Find Technologies

  • A Transgenic Mouse Model for Tetracycline Regulated Gene Expression in the Mouse Epidermis
    •
       Ref: | Updated: Jun 16, 2010 |
  • Mouse Model for the Preclinical Study of Metastatic Disease
    •
       Ref: E-296-2012 | Updated: Jun 07, 2018 | NCI
  • New Cancer Research Model: Spontaneously Transformed Mouse Epithelial Cancer Cell Lines
    •    Ref: E-089-2010 | Updated: Mar 09, 2018 | NCI
  • Genetically Engineered Mouse-Derived Allograft for Preclinical Studies of Metastatic Melanoma
    •
       Ref: E-291-2015 | Updated: Jul 19, 2018 | NCI
  • Transgenic Human Interleukin-21 Mouse Model
    •
       Ref: E-231-2010-0 | Updated: Jan 18, 2012 | NHLBI
  • Transgenic Mouse Model of Human Basal Triple Negative Breast Cancer
    •
       Ref: E-191-2010 | Updated: Dec 14, 2018 | NCI
  • Immunocompetent Mouse Model for Tracking Cancer Progression
    •
       Ref: E-173-2010 | Updated: Jun 18, 2018 | NCI
  • A Mouse Model for Human Osteoarthritis
    •
       Ref: E-081-2002-0 | Updated: Jun 16, 2010 | NIDCR
  • Metastatic ovarian cancer mouse models and cell lines for preclinical studies
    •
       Ref: E-069-2012 | Updated: Nov 20, 2017 | NCI
  • A Tet-Regulated Mouse Model for Cataract
    •
       Ref: E-316-2002-0 | Updated: Jun 16, 2010 | NIEHS
  • A Mouse Model for Type 2 Diabetes
    •
       Ref: E-132-2003-0 | Updated: Jun 16, 2010 | NIDDK
  • Mouse Xenograft Model for Mesothelioma
    •
       Ref: E-302-2009 | Updated: Mar 27, 2018 | NCI
  • A Transgenic Mouse Model for Tetracycline Regulation of Active TGFbeta1 in Mice: tetO TGFbeta1
    •
       Ref: | Updated: Jun 16, 2010 |
  • A Preclinical Model for Mutant Human EGFR-driven Lung Adenocarcinoma
    •
       Ref: E-041-2014 | Updated: Dec 15, 2020 | NCI
  • mEpoR Knockout/Tg(hEpoR) Mouse Model for Anemia and Renal Function Studies
    •
       Ref: E-127-2001-0 | Updated: Feb 12, 2015 | NIDDK
  • Transgenic Mouse Model for Lupus and Other Autoimmune Diseases
    •
       Ref: E-128-2007-0 | Updated: Aug 03, 2010 | NIAID
  • mGluR5 Tumor Mouse Model
    •
       Ref: E-123-2010-0 | Updated: Sep 29, 2011 | NINDS
  • A Mouse Model of Multiple Endocrine Neoplasia, Type I
    •
       Ref: E-243-2001-0 | Updated: Mar 10, 2014 | NHGRI
  • Mouse Anti-Mouse CXCL9 (Mig) Monoclonal Antibodies
    •
       Ref: E-198-2009-0 | Updated: Oct 12, 2010 | NIAID
  • Humanized Mouse Model to Study Mesothelin (MSLN) -targeted Cancer Therapeutics: Bl6/TPO Mice
    •
       Ref: E-096-2020 | Updated: Aug 17, 2020 | NCI
  • A Preclinical Orthotopic Model for Glioblastoma Multiforme that Represents Key Pathways Aberrant in Human Brain Cancer
    •
       Ref: E-246-2014 | Updated: Dec 15, 2020 | NCI
  • Mouse Model of STAT5 for the Drug Screen and the Research of Cancer and Autoimmunity
    •
       Ref: E-080-2011-0 | Updated: Jun 13, 2012 | NHLBI
  • A Mouse Model for Systemic Inflammation in Glucocerebrosidase-Deficient Mice with Minimal Glucosylceramide Storage
    •
       Ref: E-256-2003-0 | Updated: Dec 01, 2003 | NIDDK
  • Mouse Model for Cerebral Cavernous Malformation, an Inherited Brain Disorder
    •
       Ref: E-158-2011-0 | Updated: Jun 15, 2011 | NHLBI
  • Murine Cell Models for Metastatic Squamous Cell Carcinoma
    •
       Ref: E-213-2016-0 | Updated: Jun 22, 2016 | NIDCD
  • Mouse Strain Deficient for the Protein MT1-MMP (MMP14)
    •
       Ref: | Updated: Aug 01, 2000 |
  • Mouse Model for Myasthenia Gravis
    •
       Ref: | Updated: Jun 16, 2010 |
  • Mouse Model for Methylmalonic Acidemia, an Inherited Metabolic Disorder
    •
       Ref: E-285-2011-1 | Updated: Dec 03, 2013 | NHGRI
  • Alb-tTA (Tg(Alb1-tTA)3123Lng) Mouse Model for Liver Function Studies
    •
       Ref: E-125-2012-0 | Updated: Apr 18, 2017 | NIDDK
  • Gs Alpha LoxP (Gnastm1Lsw) Mouse Model for Metabolism Studies
    •
       Ref: E-117-2012-0 | Updated: Feb 12, 2015 | NIDDK
  • MUP-tTA Mouse Model for Liver Function Studies
    •
       Ref: E-126-2012-0 | Updated: Apr 17, 2017 | NIDDK
  • Mouse Model and Derived Cells That Hypersecrete Leukemia Inhibitory Factor (LIF)
    •
       Ref: E-175-2011-0 | Updated: May 03, 2016 | NIEHS
  • WNT1-Induced Secreted Protein-1 Knockout Mouse Model
    •
       Ref: E-234-2015-0 | Updated: Aug 06, 2015 | NIDCR
  • Leucine Rich Repeats and Calponin Homology Containing Protein 4 (Lrch4)-deficient Mouse
    •
       Ref: E-179-2014-0 | Updated: Aug 05, 2015 | NIEHS
  • Model for Study of Glomerular Disorders: Conditionally-Immortalized Mouse Podocyte Cell Line with Tet-on-Regulated Gene Expression
    •
       Ref: E-049-2007-0 | Updated: May 14, 2018 | NIDDK
  • Mouse Lacking the Chemokine Receptor CX3CR1
    •
       Ref: E-216-2003-0 | Updated: Mar 01, 2010 | NIAID
  • Tg(MMTV-Cre)#Mam Mouse Model for Developmental Biology, Hepatology, and Oncology Studies
    •
       Ref: E-113-2012-0 | Updated: Apr 17, 2017 | NIDDK
  • Transgenic Mouse Model for Tooth Disorders such as Dentin Dysplasia and Dentinogenesis Imperfecta
    •
       Ref: | Updated: Jun 16, 2010 |
  • A Mouse with a Targeted Mutation in the Uncoupling Protein-3 (upc3) Gene
    •
       Ref: E-031-1999-0 | Updated: Jun 16, 2010 |
  • Transgenic Mice with Conditionally-Enhanced Bone Morphogen Protein (BMP) Signaling: A Model for Human Bone Diseases
    •
       Ref: E-328-2008-0 | Updated: Jun 16, 2010 | NIEHS
  • Stat5a Knockout (Stat5atm1Mam) Mouse Model for Mammopoietic and Lactogenic Signaling Studies
    •
       Ref: E-116-2012-0 | Updated: Feb 12, 2015 | NIDDK
  • UTX LoxP Mouse Model for Oncology Research
    •
       Ref: E-118-2012-0 | Updated: Feb 23, 2016 | NIDDK
  • Sirt6 LoxP (Sirt6tm1.1Cxd) Mouse Model for Liver Studies
    •
       Ref: E-121-2012-0 | Updated: May 14, 2018 | NIDDK
  • Fgfr2 Knockout (Fgfr2tm1Cxd) Mouse Model for Developmental Biology Studies
    •
       Ref: E-124-2012-0 | Updated: May 14, 2018 | NIDDK
  • Mouse Model for Study of Diabetic Nephropathy and Role of Soluble Epoxide Hydrolase
    •
       Ref: E-292-2015-0 | Updated: May 24, 2016 | NIEHS
  • M5 Muscarinic Receptor Knockout (Chrm5tm1Jwe) Mouse Model for Neurological Studies
    •
       Ref: E-110-2012-0 | Updated: Apr 17, 2017 | NIDDK
  • Fgfr3 Knockout Mouse Model for Developmental Biology Studies
    •
       Ref: E-123-2012-0 | Updated: May 14, 2018 | NIDDK
  • Sirt1 LoxP (Sirt1tm1Cxd) Mouse Model for Metabolism and Hepatology Studies
    •
       Ref: E-122-2012-0 | Updated: May 14, 2018 | NIDDK
  • Stat5a LoxP/Stat5b LoxP (Stat5a/Stat5btm2Mam) Mouse Model for Mammopoietic and Lactogenic Signaling Studies
    •
       Ref: E-114-2012-0 | Updated: Feb 12, 2015 | NIDDK
  • Fgfr4 Knockout Mouse Model for Respiratory System Studies
    •
       Ref: E-125-2000-0 | Updated: May 14, 2018 | NIDDK
  • A Nurr1-Knockout Mouse Model for Parkinson's Disease and Stem Cell Differentiation
    •
       Ref: E-024-1999-0 | Updated: Aug 31, 2010 | NIDDK
  • NAG-1 Transgenic Mouse Model
    •
       Ref: E-093-2011-0 | Updated: Apr 17, 2013 | NIEHS
  • Bcl-x LoxP (Bcl2l1 tm1.1Mam) Mouse Model for Developmental Biology Studies
    •
       Ref: E-115-2012-0 | Updated: Mar 10, 2014 | NIDDK
  • Stat1LoxP (Stat1 tm1Mam ) Mouse Model for Oncology and Immunology Studies
    •
       Ref: E-111-2012-0 | Updated: Mar 10, 2014 | NIDDK
  • Tg(Wap-cre)11738Mam Mouse Model for Developmental Biology Studies
    •
       Ref: E-112-2012-0 | Updated: Apr 19, 2012 | NIDDK
  • T-Cell-Specific Gfi-1 Knockout Mouse
    •
       Ref: E-242-2009-0 | Updated: May 16, 2018 | NIAID
  • Smad4 Knockout (Smad4tm1Cxd) Mouse Model for Developmental Biology Studies
    •
       Ref: E-133-1999-0 | Updated: May 14, 2018 | NIDDK
  • Sirt3 Knockout (Sirt3tm1.1Cxd) Mouse Model for Cardiology and Metabolism Studies
    •
       Ref: E-119-2012-0 | Updated: May 14, 2018 | NIDDK
  • Sirt1 Knockout (Sirt1tm1.1Cxd) Mouse Model for Oncology and Metabolism Studies
    •
       Ref: E-120-2012-0 | Updated: May 14, 2018 | NIDDK
  • New Mouse Strain with Conditional Deletion of SMAD7: Analysis of Disease Processes Involving Immunological, Fibrotic or Cardiovascular Indications
    •
       Ref: E-040-2010-0 | Updated: Sep 04, 2020 | NIEHS
  • mNFHcre Transgenic Mice
    •
       Ref: E-293-2009-0 | Updated: Aug 10, 2015 | NIDCR
  • Novel Genetic Tristetraprolin (TTP) Knock-in Mouse
    •
       Ref: E-287-2014-0 | Updated: Aug 05, 2015 | NIEHS
  • Conditional V2 Vasopressin Receptor Mutant Mice as a Model to Study X-linked Nephrogenic Diabetes Insipidus (XNDI)
    •
       Ref: E-174-2009-0 | Updated: Jul 12, 2017 | NIDDK
  • Fibroblast Growth Factor Receptor 1 (Fgfr1) Conditional Knock Out Mouse
    •
       Ref: E-071-2011-0 | Updated: May 14, 2018 | NIDDK
  • Leucine Zipper-bearing Kinase (LZK) -Targeting Degraders and Methods of Use
    •
       Ref: E-163-2020 | Updated: Nov 30, 2020 | NCI
  • AlphaB-Crystallin/HSPBE Gene Knockout Mouse
    •
       Ref: | Updated: Jun 16, 2010 |
  • IL7Rα-Specific Antibody for Treating Acute Lymphoblastic Leukemia (ALL)
    •
       Ref: E-247-2015 | Updated: Jan 17, 2018 | NCI
  • CC Chemokine Receptor 5 DNA, New Animal Models and Therapeutic Agents for HIV Infection
    •
       Ref: E-090-1996-0 | Updated: Jun 01, 2007 | NIAID
  • Hspa2 Knockout Mice for Study of Spermatogenesis and Male Infertility
    •
       Ref: E-052-2011-0 | Updated: Sep 04, 2020 | NIEHS
  • Knockout and Conditional Knockout Mice-GPR116
    •    Ref: E-269-2012 | Updated: Apr 23, 2018 | NCI
  • The Use of Rabbits with Defined Immunoglobulin Light Chain Genes (Ckappa b allotypes) to Optimize Production of Chimeric and Humanized Monoclonal Antibodies for Therapeutic, Imaging and Diagnostic Applications
    •
       Ref: E-332-2004-0 | Updated: Dec 01, 2004 | NIAID
  • Serotonin-Deficient Knock-out Mouse
    •
       Ref: B-019-1999-0 | Updated: Jun 05, 2018 | NIMH
  • Bioluminescent Bladder Cancer Cell Line for Tracking Cancer Progression
    •    Ref: E-237-2018 | Updated: Nov 08, 2018 | NCI
  • Use of the TP5 Peptide for the Treatment of Cancer
    •
       Ref: E-007-2019 | Updated: Oct 06, 2020 | NCI
  • Treatment and Prevention of Inflammatory Bowel Disease (IBD) using Mutant and Chimeric IL-13 Molecules
    •
       Ref: E-003-2005-0 | Updated: Jul 31, 2012 | NIAID
  • Small Molecule MRS5474 with Anticonvulsant Activity for Treatment of Epilepsy
    •
       Ref: E-285-2008-1 | Updated: Aug 31, 2016 | NIDDK
  • Human Erythropoietin Receptor Transgenic Mice
    •
       Ref: | Updated: Jun 16, 2010 |
  • Cytochromes P450 CYP2J and CYP2C Polyclonal Antibodies and Recombinant Proteins
    •
       Ref: E-153-2011-0 | Updated: Sep 04, 2020 | NIEHS
  • Therapeutic Immunotoxins with Increased Half-Life and Anti-Tumor Activity
    •
       Ref: E-179-2019 | Updated: Aug 17, 2020 | NCI
  • Zika Virus VLP (Virus-like Particle) Antigens for Vaccine Candidate and Diagnostic Development
    •
       Ref: E-107-2016-0 | Updated: Mar 09, 2020 | CDC
  • Anti-Mesothelin Monoclonal Antibodies for the Treatment of Cancer
    •
       Ref: E-236-2012 | Updated: Jun 07, 2018 | NCI
  • Tristetraprolin (TTP) Knockout Mice
    •
       Ref: B-015-1999-0 | Updated: Jun 16, 2010 | NIEHS
  • Generation of Smad3-null Mice and Smad4-conditional Mice
    •
       Ref: E-349-2003-0 | Updated: May 14, 2018 | NIDDK
  • Transgenic Hspa2-Cre Mice for Studying Spermatogenesis and Male Infertility
    •
       Ref: E-290-2011-0 | Updated: Sep 04, 2020 | NIEHS
  • Natural product-based anti-cancer agents: aza-Englerin analogues
    •
       Ref: E-090-2014 | Updated: Dec 20, 2017 | NCI
  • Antibodies Against TL1A, a TNF-Family Cytokine, for the Treatment and Diagnosis of Autoimmune Inflammatory Diseases
    •
       Ref: E-073-2011-1 | Updated: Sep 12, 2012 | NIAMS
  • Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
    •
       Ref: E-256-2015-0 | Updated: Feb 27, 2018 | NIAID
  • Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
    •
       Ref: E-293-1999-0 | Updated: Jul 06, 2017 | NIDCR
  • Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
    •
       Ref: E-120-2013-0 | Updated: Oct 02, 2017 | NIAID
  • Transgenic Mice Expressing Human Arginase II Gene in Endothelium: Useful for Studying Atherosclerosis and Other Vasculopathies
    •
       Ref: E-255-2010-0 | Updated: Aug 30, 2011 | NHLBI
  • Design and Biological Activity of Novel Stealth Polymeric Lipid Nanoparticles for Enhanced Delivery of Hydrophobic Photodynamic Therapy Drugs
    •
       Ref: E-154-2018 | Updated: Nov 19, 2019 | NCI
  • Potential Use of anti-IgE in the Treatment of Lupus Nephritis
    •
       Ref: E-216-2010-0 | Updated: Mar 27, 2012 | NIAMS
  • Therapeutic Approach to Neurodegenerative Disorders Using a TFP5-Peptide
    •
       Ref: E-144-2010-0 | Updated: May 05, 2016 | NINDS
  • Genomics-based Diagnostic Assay for Cancer
    •
       Ref: E-023-2009 | Updated: Jul 19, 2018 | NCI
  • New Targeted Therapy for Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
    •
       Ref: E-060-2011-0 | Updated: Sep 10, 2012 | NHGRI
  • Mice Genetically Deficient in the Chemoattractant Receptor FPR (formyl peptide receptor)
    •
       Ref: E-258-2007-0 | Updated: Sep 19, 2017 | NIAID
  • Zuma Mutant Mice as a Tool for Investigating Mammalian Developmental Defects
    •
       Ref: E-294-2012-0 | Updated: Oct 22, 2012 | NHGRI
  • Human Cancer Therapy Using Engineered Anthrax Lethal Toxin
    •
       Ref: E-070-2007-2 | Updated: Jun 16, 2010 | NIAID
  • Assay to Screen Anti-metastatic Drugs
    •
       Ref: E-088-2013 | Updated: Jun 07, 2018 | NCI
  • Novel Peptide of Streptococcus pneumoniae Surface Adhesion A (PsaA) Protein Associated with Adherence and Uses Thereof – for Vaccine Candidate, Therapeutic and Diagnostic Development
    •
       Ref: E-338-2013-0 | Updated: Jun 13, 2018 | CDC

    Pages


    Displaying 1 - 100 of 157

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057